JENNIFER KAY WILCOX
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family JAMESTOWN, NY NPI 1134438567
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NY Gilead Sciences, Inc. All categories
General Payments — all program years on this page
$7,048.73
- Category: General Payments
- Program years: PY2021–2024
- Record count: 103
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $6,368.93 across 78 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $2,261.21 | 7 |
| Consulting Fee | $2,140.00 | 1 |
| Food and Beverage | $1,967.72 | 70 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $5,277.06 | 26 |
| Novo Nordisk AS | $214.70 | 14 |
| GENZYME CORPORATION | $124.97 | 1 |
| PFIZER INC. | $110.68 | 5 |
| Acerta Pharma LLC | $107.61 | 6 |
| Lilly USA, LLC | $51.67 | 3 |
| Astellas Pharma US Inc | $51.07 | 2 |
| Mylan Specialty L.P. | $50.05 | 3 |
| Sumitomo Pharma America, Inc. | $49.97 | 2 |
| BAXTER HEALTHCARE | $48.75 | 1 |
| GlaxoSmithKline, LLC. | $36.95 | 2 |
| SHIELD THERAPEUTICS INC | $32.11 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.02 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.67 | 1 |
| IBSA Pharma Inc. | $24.06 | 1 |
| Exact Sciences Corporation | $21.13 | 1 |
| DEXCOM, INC. | $20.31 | 1 |
| Corcept Therapeutics | $19.97 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.24 | 1 |
| Amgen Inc. | $17.81 | 1 |
| ITI, Inc. | $17.42 | 1 |
| Lundbeck LLC | $16.71 | 1 |
By program year
Records — PY2024 (78)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.